Yi-Ming Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi-Ming Shi has a total of 331 co-authors. Here are the top co-authors by number of shared publications:
- Helge Bjoern Bode
Department of Natural Products in Organismic Interactions, Max-Planck-Institute for Terrestrial Microbiology, Marburg, Germany
26 shared publications Han-Dong Sun
State Key Laboratory of Phytochemistry and Plant Resources in West China , Kunming Institute of Botany, Chinese Academy of Sciences , Kunming 650201 , Yunnan , People's Republic of China
14 shared publicationsXiao-Nian Li
State Key Laboratory of Phytochemistry and Plant Resources in West China , Kunming Institute of Botany, Chinese Academy of Sciences , Kunming 650201 , Yunnan , People's Republic of China
14 shared publicationsXue Du
State Key Laboratory of Phytochemistry and Plant Resources in West China , Kunming Institute of Botany, Chinese Academy of Sciences , Kunming 650201 , Yunnan , People's Republic of China
14 shared publications- Han-Dong Sun
State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China
12 shared publications Wei-Lie Xiao
State Key Laboratory of Phytochemistry and Plant Resources in West China , Kunming Institute of Botany, Chinese Academy of Sciences , Kunming 650201 , Yunnan , People's Republic of China
12 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (35) , 38069-38079
Total Synthesis and Structural Revision of Rhabdobranin Reveals a Cryptic Gram-Negative Antibiotic
Gram-negative bacteria present a major clinical challenge but also remain an underexplored source of antibacterial natural products. Resistance-guided genome mining of the entomopathogenic symbiont Xenorhabdus identified the rdb biosynthetic gene cluster, which encodes a putative prodrug antibiotic, pre-rhabdobranin. However, the inability to isolate the proposed active metabolite, rhabdobranin, has prevented direct functional evaluation. Here we report a convergent total synthesis of the proposed structure of pre-rhabdobranin B, which revealed a stereochemical misassignment at the N-terminal arginine residue. Synthesis of both rhabdobranin epimers showed that, although they are nearly indistinguishable by standard analytical methods, inversion at this single stereocenter has a pronounced effect on antibacterial activity. Biological evaluation of the revised rhabdobranin structure revealed potent antibacterial activity against Gram-negative pathogens, including WHO critical-priority carbapenem-resistant Klebsiella pneumoniae. Cellular and biochemical profiling implicated inhibition of protein biosynthesis as its principal antibacterial mechanism. We further show that the GNAT-family acetyltransferase RdbK N-acetylates rhabdobranin, attenuating its activity and establishing a secondary self-resistance mechanism. These findings validate resistance-gene-guided discovery in Gram-negative symbionts as a strategy for uncovering cryptic antibiotics and identify rhabdobranin as a promising scaffold for Gram-negative antibiotic development.
- 27 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (35) , 38069-38079
Open AccessTotal Synthesis and Structural Revision of Rhabdobranin Reveals a Cryptic Gram-Negative Antibiotic
Gram-negative bacteria present a major clinical challenge but also remain an underexplored source of antibacterial natural products. Resistance-guided genome mining of the entomopathogenic symbiont Xenorhabdus identified the rdb biosynthetic gene cluster, which encodes a putative prodrug antibiotic, pre-rhabdobranin. However, the inability to isolate the proposed active metabolite, rhabdobranin, has prevented direct functional evaluation. Here we report a convergent total synthesis of the proposed structure of pre-rhabdobranin B, which revealed a stereochemical misassignment at the N-terminal arginine residue. Synthesis of both rhabdobranin epimers showed that, although they are nearly indistinguishable by standard analytical methods, inversion at this single stereocenter has a pronounced effect on antibacterial activity. Biological evaluation of the revised rhabdobranin structure revealed potent antibacterial activity against Gram-negative pathogens, including WHO critical-priority carbapenem-resistant Klebsiella pneumoniae. Cellular and biochemical profiling implicated inhibition of protein biosynthesis as its principal antibacterial mechanism. We further show that the GNAT-family acetyltransferase RdbK N-acetylates rhabdobranin, attenuating its activity and establishing a secondary self-resistance mechanism. These findings validate resistance-gene-guided discovery in Gram-negative symbionts as a strategy for uncovering cryptic antibiotics and identify rhabdobranin as a promising scaffold for Gram-negative antibiotic development.
- 30 April 2026
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 91, 102759
From known knowns to unknown unknowns: synthetic biology paths to antimicrobial discovery
- 30 April 2026
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 91, 102759
From known knowns to unknown unknowns: synthetic biology paths to antimicrobial discovery
- Open Access
- 27 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8229-8241
Lipid-donor-anchored genome mining uncovers dioxanopeptins, antibacterial lipopeptides with a 1,3-dioxane functionalized polyunsaturated lipid tail
Lipid-donor-anchored genome mining uncovers dioxanopeptins, a series of lipopeptides with a 1,3-dioxane functionalized polyunsaturated lipid tail. They selectively inhibit MRSA by disrupting proton motive force homeostasis and ATP production.
- 27 February 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 17 (16) , 8229-8241
Open AccessLipid-donor-anchored genome mining uncovers dioxanopeptins, antibacterial lipopeptides with a 1,3-dioxane functionalized polyunsaturated lipid tail
Lipid-donor-anchored genome mining uncovers dioxanopeptins, a series of lipopeptides with a 1,3-dioxane functionalized polyunsaturated lipid tail. They selectively inhibit MRSA by disrupting proton motive force homeostasis and ATP production.
- Open Access
- 3 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Polyketide synthase-derived sphingolipids mediate microbiota protection against a bacterial pathogen in C. elegans
Protection against pathogens is a major function of the gut microbiota. Although bacterial natural products have emerged as crucial components of host-microbiota interactions, their exact role in microbiota-mediated protection is largely unexplored. We addressed this knowledge gap with the nematode Caenorhabditis elegans and its microbiota isolate Pseudomonas fluorescens MYb115 that is known to protect against Bacillus thuringiensis (Bt) infection. We find that MYb115-mediated protection depends on sphingolipids (SLs) that are derived from an iterative type I polyketide synthase (PKS) cluster PfSgaAB, thereby revealing a non-canonical pathway for the production of bacterial SLs as secondary metabolites. SL production is common in eukaryotes but was thought to be limited to a few bacterial phyla that encode the serine palmitoyltransferase (SPT) enzyme, which catalyses the initial step in SL synthesis. We demonstrate that PfSgaB encodes a pyridoxal 5’-phosphate-dependent alpha-oxoamine synthase with SPT activity, and find homologous putative PKS clusters present across host-associated bacteria that are so far unknown SL producers. Moreover, we provide evidence that MYb115-derived SLs affect C. elegans defence against Bt infection by altering SL metabolism in the nematode host. This work establishes SLs as structural outputs of bacterial PKS and highlights the role of microbiota-derived SLs in host protection against pathogens.
- 3 June 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessPolyketide synthase-derived sphingolipids mediate microbiota protection against a bacterial pathogen in C. elegans
Protection against pathogens is a major function of the gut microbiota. Although bacterial natural products have emerged as crucial components of host-microbiota interactions, their exact role in microbiota-mediated protection is largely unexplored. We addressed this knowledge gap with the nematode Caenorhabditis elegans and its microbiota isolate Pseudomonas fluorescens MYb115 that is known to protect against Bacillus thuringiensis (Bt) infection. We find that MYb115-mediated protection depends on sphingolipids (SLs) that are derived from an iterative type I polyketide synthase (PKS) cluster PfSgaAB, thereby revealing a non-canonical pathway for the production of bacterial SLs as secondary metabolites. SL production is common in eukaryotes but was thought to be limited to a few bacterial phyla that encode the serine palmitoyltransferase (SPT) enzyme, which catalyses the initial step in SL synthesis. We demonstrate that PfSgaB encodes a pyridoxal 5’-phosphate-dependent alpha-oxoamine synthase with SPT activity, and find homologous putative PKS clusters present across host-associated bacteria that are so far unknown SL producers. Moreover, we provide evidence that MYb115-derived SLs affect C. elegans defence against Bt infection by altering SL metabolism in the nematode host. This work establishes SLs as structural outputs of bacterial PKS and highlights the role of microbiota-derived SLs in host protection against pathogens.
- 12 February 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (2) , 617
Correction to “Discovery of Unusual Sesterterpenoids from Colquhounia coccinea var. mollis and Their Metabolic Implications”
- 12 February 2025
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (2) , 617
Correction to “Discovery of Unusual Sesterterpenoids from Colquhounia coccinea var. mollis and Their Metabolic Implications”
- Open Access
- 14 November 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (51)
Pyrrolizwillin, ein Einzigartiges Bakterielles Alkaloid, Gebildet durch eine Kombination aus Nichtribosomaler Peptidsynthetase und nicht‐Enzymatischer Dimerisierung
Pyrrolizidinalkaloide (PAs) sind eine strukturell vielfältige Gruppe spezialisierter heterocyclischer Metabolite, die durch eine Hexahydro‐1H‐pyrrolizin‐Kernstruktur charakterisiert werden. PAs werden über zwei unterschiedliche Biosynthesewege gebildet. In Pflanzen werden sie durch eine Homospermidinsynthase synthetisiert, während sie in Bakterien durch die kombinierte Wirkung einer nichtribosomalen Peptidsynthetase und einer Baeyer–Villiger‐Monooxygenase entstehen. Während die toxischen Eigenschaften pflanzlicher PAs und ihr Vorkommen in tierischen und menschlichen Lebensmitteln umfassend untersucht wurden, sind die biologischen Funktionen und die Biosynthese komplexerer bakterieller PAs noch nicht gut verstanden. Hier berichten wir über die Identifizierung und Charakterisierung eines bakteriellen Biosynthese‐Genclusters aus Xenorhabdus hominickii, xhpA‐G, das für die Produktion des PA‐Pseudodimers Pyrrolizwillin verantwortlich ist. Die Analyse von Promotor‐Austauschmutanten aus X. hominickii zusammen mit der heterologen Expression von xhpA‐G in E. coli ergab eine Reihe von Derivaten und Zwischenprodukten, von denen zwei chemisch synthetisiert wurden. Diese Informationen wurden genutzt, um einen detaillierten Biosyntheseweg zu Pyrrolizwillin zu postulieren. Darüber hinaus haben wir die Hydrolase XhpG, das Schlüsselenzym bei der Umwandlung des Zwischenprodukts Pyrrolizixenamid zu Pyrrolizwillin, mittels Röntgenkristallographie und Kleinwinkel‐Röntgenstreuung (SAXS) charakterisiert.
- 14 November 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (51)
Open AccessPyrrolizwillin, ein Einzigartiges Bakterielles Alkaloid, Gebildet durch eine Kombination aus Nichtribosomaler Peptidsynthetase und nicht‐Enzymatischer Dimerisierung
Pyrrolizidinalkaloide (PAs) sind eine strukturell vielfältige Gruppe spezialisierter heterocyclischer Metabolite, die durch eine Hexahydro‐1H‐pyrrolizin‐Kernstruktur charakterisiert werden. PAs werden über zwei unterschiedliche Biosynthesewege gebildet. In Pflanzen werden sie durch eine Homospermidinsynthase synthetisiert, während sie in Bakterien durch die kombinierte Wirkung einer nichtribosomalen Peptidsynthetase und einer Baeyer–Villiger‐Monooxygenase entstehen. Während die toxischen Eigenschaften pflanzlicher PAs und ihr Vorkommen in tierischen und menschlichen Lebensmitteln umfassend untersucht wurden, sind die biologischen Funktionen und die Biosynthese komplexerer bakterieller PAs noch nicht gut verstanden. Hier berichten wir über die Identifizierung und Charakterisierung eines bakteriellen Biosynthese‐Genclusters aus Xenorhabdus hominickii, xhpA‐G, das für die Produktion des PA‐Pseudodimers Pyrrolizwillin verantwortlich ist. Die Analyse von Promotor‐Austauschmutanten aus X. hominickii zusammen mit der heterologen Expression von xhpA‐G in E. coli ergab eine Reihe von Derivaten und Zwischenprodukten, von denen zwei chemisch synthetisiert wurden. Diese Informationen wurden genutzt, um einen detaillierten Biosyntheseweg zu Pyrrolizwillin zu postulieren. Darüber hinaus haben wir die Hydrolase XhpG, das Schlüsselenzym bei der Umwandlung des Zwischenprodukts Pyrrolizixenamid zu Pyrrolizwillin, mittels Röntgenkristallographie und Kleinwinkel‐Röntgenstreuung (SAXS) charakterisiert.
- Open Access
- 14 November 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (51) , e202411258
Pyrrolizwilline, a Unique Bacterial Alkaloid Assembled by a Nonribosomal Peptide Synthetase and non‐Enzymatic Dimerization
Pyrrolizidine alkaloids (PAs) are a structurally diverse group of heterocyclic specialized metabolites characterized by a core structure comprising a hexahydro‐1H‐pyrrolizine. PAs are synthesized through two main pathways. In plants, assembly occurs via a homospermidine synthase, and in bacteria, through combined action of a nonribosomal peptide synthetase and a Baeyer–Villiger monooxygenase. While the toxic properties of plant‐derived PAs and their prevalence in animal and human foods have been extensively studied, the biological roles and biosynthesis of more complex bacterial PAs are not well understood. Here, we report the identification and characterization of a bacterial biosynthetic gene cluster from Xenorhabdus hominickii, xhpA‐G, which is responsible for producing the PA pseudo‐dimer pyrrolizwilline. Analysis of X. hominickii promoter exchange mutants together with heterologous expression of xhpA‐G in E. coli, revealed a set of pathway intermediates, two of which were chemically synthesized, as well as multiple derivatives. This information was leveraged to propose a detailed biosynthetic pathway to pyrrolizwilline. Furthermore, we have characterized the hydrolase XhpG, the key enzyme in the conversion of the pathway intermediate pyrrolizixenamide to pyrrolizwilline, using X‐ray crystallography and small‐angle X‐ray scattering (SAXS).
- 14 November 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (51) , e202411258
Open AccessPyrrolizwilline, a Unique Bacterial Alkaloid Assembled by a Nonribosomal Peptide Synthetase and non‐Enzymatic Dimerization
Pyrrolizidine alkaloids (PAs) are a structurally diverse group of heterocyclic specialized metabolites characterized by a core structure comprising a hexahydro‐1H‐pyrrolizine. PAs are synthesized through two main pathways. In plants, assembly occurs via a homospermidine synthase, and in bacteria, through combined action of a nonribosomal peptide synthetase and a Baeyer–Villiger monooxygenase. While the toxic properties of plant‐derived PAs and their prevalence in animal and human foods have been extensively studied, the biological roles and biosynthesis of more complex bacterial PAs are not well understood. Here, we report the identification and characterization of a bacterial biosynthetic gene cluster from Xenorhabdus hominickii, xhpA‐G, which is responsible for producing the PA pseudo‐dimer pyrrolizwilline. Analysis of X. hominickii promoter exchange mutants together with heterologous expression of xhpA‐G in E. coli, revealed a set of pathway intermediates, two of which were chemically synthesized, as well as multiple derivatives. This information was leveraged to propose a detailed biosynthetic pathway to pyrrolizwilline. Furthermore, we have characterized the hydrolase XhpG, the key enzyme in the conversion of the pathway intermediate pyrrolizixenamide to pyrrolizwilline, using X‐ray crystallography and small‐angle X‐ray scattering (SAXS).
- 8 November 2024
- Published by Wiley in ChemMedChem
- Vol. 19 (24) , e202400469
Bacterial Secondary Metabolites Embedded in Producer Cell Membranes and Antibiotics Targeting Their Biosynthesis
The bacterial cell membrane primarily houses lipids, carbohydrates, and proteins forming a barrier and interface that maintains cellular integrity, supports homeostasis, and senses environmental changes. Compared to lipid components and excreted secondary metabolites, compounds embedded in the producer cell membrane are often overlooked due to their low abundance and niche‐specific functions. The accumulation of findings has led to an increased appreciation of their crucial roles in bacterial cell biochemistry, physiology, and ecology, as well as their impact on mutualistic and pathogenic bacteria‐eukaryote interactions. This review highlights the structures, biosynthesis, regulation, and ecological functions of membrane‐embedded secondary metabolites. It also discusses antibiotics that target their biosynthetic pathways, aiming to inspire the development of antibiotics specific to pathogenic bacteria without harming human cells.
- 8 November 2024
- Published by Wiley in ChemMedChem
- Vol. 19 (24) , e202400469
Bacterial Secondary Metabolites Embedded in Producer Cell Membranes and Antibiotics Targeting Their Biosynthesis
The bacterial cell membrane primarily houses lipids, carbohydrates, and proteins forming a barrier and interface that maintains cellular integrity, supports homeostasis, and senses environmental changes. Compared to lipid components and excreted secondary metabolites, compounds embedded in the producer cell membrane are often overlooked due to their low abundance and niche‐specific functions. The accumulation of findings has led to an increased appreciation of their crucial roles in bacterial cell biochemistry, physiology, and ecology, as well as their impact on mutualistic and pathogenic bacteria‐eukaryote interactions. This review highlights the structures, biosynthesis, regulation, and ecological functions of membrane‐embedded secondary metabolites. It also discusses antibiotics that target their biosynthetic pathways, aiming to inspire the development of antibiotics specific to pathogenic bacteria without harming human cells.
- Open Access
- 24 September 2024
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 41 (11) , 1630-1651
Exploring nature's battlefield: organismic interactions in the discovery of bioactive natural products
This review highlights the discovery of functional microbial natural products from diverse niches. Leveraging the biosynthetic capabilities of microbes in organismic interactions is crucial for tackling antimicrobial resistance.
- 24 September 2024
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 41 (11) , 1630-1651
Open AccessExploring nature's battlefield: organismic interactions in the discovery of bioactive natural products
This review highlights the discovery of functional microbial natural products from diverse niches. Leveraging the biosynthetic capabilities of microbes in organismic interactions is crucial for tackling antimicrobial resistance.
- Open Access
Polyketide synthase-derived sphingolipids determine microbiota-mediated protection against pathogens in C. elegans
Protection against pathogens is a major function of the gut microbiota. Although bacterial natural products have emerged as crucial components of host-microbiota interactions, their exact role in microbiota-mediated protection is largely unexplored. We addressed this knowledge gap with the nematode Caenorhabditis elegans and its microbiota isolate Pseudomonas fluorescens MYb115 that is known to protect against Bacillus thuringiensis (Bt) infection. We find that MYb115-mediated protection depends on sphingolipids that are derived from an iterative type I polyketide synthase (PKS), thereby describing a noncanonical pathway of bacterial sphingolipid production. We provide evidence that MYb115-derived sphingolipids affect C. elegans tolerance to Bt infection by altering host sphingolipid metabolism. This work establishes sphingolipids as structural outputs of bacterial PKS and highlights the role of microbiota-derived sphingolipids in host protection against pathogens.
Open AccessPolyketide synthase-derived sphingolipids determine microbiota-mediated protection against pathogens in C. elegans
Protection against pathogens is a major function of the gut microbiota. Although bacterial natural products have emerged as crucial components of host-microbiota interactions, their exact role in microbiota-mediated protection is largely unexplored. We addressed this knowledge gap with the nematode Caenorhabditis elegans and its microbiota isolate Pseudomonas fluorescens MYb115 that is known to protect against Bacillus thuringiensis (Bt) infection. We find that MYb115-mediated protection depends on sphingolipids that are derived from an iterative type I polyketide synthase (PKS), thereby describing a noncanonical pathway of bacterial sphingolipid production. We provide evidence that MYb115-derived sphingolipids affect C. elegans tolerance to Bt infection by altering host sphingolipid metabolism. This work establishes sphingolipids as structural outputs of bacterial PKS and highlights the role of microbiota-derived sphingolipids in host protection against pathogens.